The Republican-led Senate Health Committee voted Wednesday to advance legislation over the objection of its chair to cap the cost of insulin at $35 a month for diabetes patients on private insurance.
One of the chief sponsors of the INSULIN Act is Maine Republican Susan Collins, who Democrats are banking on beating in November in order to regain control of the chamber.
Collins immediately touted the bill’s committee approval in a statement, saying that it showed how effective she is at working with Democrats. “Too many patients struggling to afford lifesaving insulin,” she said. “I will keep working across the aisle to lower costs, strengthen…
Read the full article at POLITICO.COM
